Valuation : Virbac

Market Cap 264.74Cr 307.8Cr 249.03Cr 227.29Cr 424.17Cr 29TCr 426.32Cr 2.95TCr 1.14TCr 15TCr 1.16TCr 1.13TCr 47TCr P/E 2026 *
15.5x
P/E 2027 * 14x
Enterprise Value 277.41Cr 322.54Cr 260.96Cr 238.17Cr 444.48Cr 31TCr 446.73Cr 3.09TCr 1.2TCr 16TCr 1.21TCr 1.18TCr 50TCr EV / Sales 2026 *
1.79x
EV / Sales 2027 * 1.65x
Free-Float
49.03%
Yield 2026 *
0.55%
Yield 2027 * 0.65%
1 day+1.51%
1 week-1.70%
Current month-1.70%
1 month-7.68%
3 months-9.52%
6 months-8.87%
Current year-10.16%
1 week 313
Extreme 313
326
1 month 313
Extreme 313
346
Current year 313
Extreme 313
385.5
1 year 296
Extreme 296
385.5
3 years 242
Extreme 242
399
5 years 215.5
Extreme 215.5
447
10 years 102.86
Extreme 102.85567
447
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
+1.51%-1.70% - - 305.89Cr
-2.97%-4.59%-52.02%-60.83% 3.13TCr
-2.16%+0.21%+30.06%+105.22% 1.22TCr
+2.32%+2.08%-9.82%+7.56% 395.52Cr
+0.64%-2.02%-2.47%+18.35% 305.89Cr
+0.98%-1.58%+52.02%+34.71% 199.72Cr
-0.44%-3.28%+11.60%+13.17% 188.18Cr
-2.46%-1.14%-5.42%+198.96% 155.3Cr
-0.33%+4.74%-16.23%+0.22% 122.99Cr
+2.27%+5.42%-3.23%-37.34% 107.1Cr
Average -0.06%+1.15%+0.50%+31.11% 647.94Cr
Weighted average by Cap. -1.70%-0.35%-20.82%-2.88%

Financials

2026 *2027 *
Net sales 155.09Cr 180.32Cr 145.89Cr 133.15Cr 248.5Cr 17TCr 249.75Cr 1.73TCr 668.4Cr 8.74TCr 677.01Cr 662.06Cr 28TCr 164.73Cr 191.53Cr 154.96Cr 141.43Cr 263.94Cr 18TCr 265.27Cr 1.84TCr 709.94Cr 9.28TCr 719.08Cr 703.2Cr 29TCr
Net income 17Cr 20Cr 16Cr 15Cr 27Cr 1.89TCr 28Cr 190.68Cr 74Cr 964.34Cr 75Cr 73Cr 3.05TCr 19Cr 22Cr 18Cr 16Cr 30Cr 2.09TCr 31Cr 211.22Cr 82Cr 1.07TCr 83Cr 81Cr 3.38TCr
Net Debt 13Cr 15Cr 12Cr 11Cr 20Cr 1.4TCr 20Cr 141.24Cr 55Cr 714.29Cr 55Cr 54Cr 2.26TCr 7.52Cr 8.74Cr 7.07Cr 6.45Cr 12Cr 828.7Cr 12Cr 84Cr 32Cr 423.57Cr 33Cr 32Cr 1.34TCr
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
08/26/08 €318.00 +1.11% 1
07/26/07 €314.50 -1.10% 0
04/26/04 €318.00 -1.40% 1
03/26/03 €322.50 +0.31% 157
02/26/02 €321.50 -0.77% 637
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
316.00EUR
Average target price
411.88EUR
Spread / Average Target
+30.34%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!